Browse > Article
http://dx.doi.org/10.7314/APJCP.2014.15.3.1447

Association between the Metabolic Syndrome and High Tumor Grade and Stage of Primary Urothelial Cell Carcinoma of the Bladder  

Ozbek, Emin (Okmeydani Training and Research Hospital Department of Urology)
Otunctemur, Alper (Okmeydani Training and Research Hospital Department of Urology)
Dursun, Murat (Okmeydani Training and Research Hospital Department of Urology)
Koklu, Ismail (Okmeydani Training and Research Hospital Department of Urology)
Sahin, Suleyman (Okmeydani Training and Research Hospital Department of Urology)
Besiroglu, Huseyin (Okmeydani Training and Research Hospital Department of Urology)
Erkoc, Mustafa (Okmeydani Training and Research Hospital Department of Urology)
Danis, Eyyup (Okmeydani Training and Research Hospital Department of Urology)
Bozkurt, Muammer (Okmeydani Training and Research Hospital Department of Urology)
Publication Information
Asian Pacific Journal of Cancer Prevention / v.15, no.3, 2014 , pp. 1447-1451 More about this Journal
Abstract
Purpose: To compare histopathologic findings of patients who underwent transurethral resection of a bladder tumor (TUR-B) between groups with and without the metabolic syndrome. Materials and Methods: We retrospectively analyzed data of 535 patients who underwent TUR-B in our department between October 2005 and March 2011. All patients had primary urethelial cell carcinoma (UCB). Histologic stage, grade, the presence of hypertension, diabetes mellitus, body mass index (BMI), waist circumference, HDL and trigliseride levels were evaluated. The TNM classification was used, with Ta tumor accepted as lower stage and T1 and T2 tumors as higher stage bladder cancers. Also, the pathological grading adopted by the 2004 World Health Organization grading system were applied. Non-invasive papillary urothelial neoplasms of low malignant potential were regarded as low grade. Results: Among the total of 509 patients analyzed in our study, there were 439 males (86.2%) and 70 females (13.8%). Metabolic syndrome was significantly associated with high histologic grade, and high pathologic stage (p<0.001). Conclusions: The patients with metabolic syndrome were found to have statistically significant higher T stage and grade of bladder cancer. Further studies with more patients are needed to confirm our study.
Keywords
Bladder cancer; metabolic syndrome; urothelial carcinom; diabetes mellitus; grade; stage;
Citations & Related Records
Times Cited By KSCI : 2  (Citation Analysis)
연도 인용수 순위
1 Reeves GK, Pirie K, Beral V, et al (2007). Cancer incidence and mortality in relation to body mass index in the Million Women Study: cohort study. BMJ, 335, 1134.   DOI   ScienceOn
2 Rosengren A, Himmelmann A, Wilhelmsen L, Branehog I, Wedel H (1998). Hypertension and long-term cancer incidence and mortality among Swedish men. J Hypertens, 16, 933-40.   DOI
3 Samanic C, Gridley G, Chow WH, et al (2004). Obesity and cancer risk among white and black United States veterans. Cancer Causes Control, 15, 35-43.   DOI
4 Samanic C, Chow WH, Gridley G, Jarvholm B, Fraumeni JF Jr (2006). Relation of body mass index to cancer risk in 362,552 Swedish men. Cancer Causes Control, 17, 901-9.   DOI   ScienceOn
5 Siegel R, Naishadham D, Jemal A (2012). Cancer statistics, 2012. CA: A Cancer J Clin, 62, 10-29.   DOI   ScienceOn
6 Stocks T, Rapp K, Bjorge T, Manjer J, Ulmer H (2009). Blood glucose and risk of incident and fatal cancer in the metabolic syndrome and cancer project (me-can): analysis of six prospective cohorts. PLoS Med, 6, 1000201.   DOI
7 Stumpe KO (2002). Hypertension and the risk of cancer: is there new evidence? J Hypertens, 20, 565-7.   DOI
8 Yang XQ, Xu C, Sun Y, Han RF (2013). Diabetes mellitus increases the risk of bladder cancer: an updated meta-analysis. Asian Pac J Cancer Prev, 14, 2583-9.   과학기술학회마을   DOI   ScienceOn
9 Zhao H, Grossman HB, Spitz MR, et al (2003). Plasma levels of insulin-like growth factor-1 and binding protein-3, and their association with bladder cancer risk. J Urol, 169, 714-7.   DOI   ScienceOn
10 Larsson SC, Andersson SO, Johansson JE, Wolk A (2008). Diabetes mellitus, body size and bladder cancer risk in a prospective study of Swedish men. Eur J Cancer, 44, 2655-60.   DOI   ScienceOn
11 Jee SH, Yun JE, Park EJ, et al (2008). Body mass index and cancer risk in Korean men and women. Int J Cancer, 123, 1892-6.   DOI   ScienceOn
12 Jee SH, Ohrr H, Sull JW, et al (2005). Fasting serum glucose level and cancer risk in Korean men and women. JAMA, 293, 194-202.   DOI   ScienceOn
13 Koebnick C, Michaud D, Moore SC, et al (2008). Body mass index, physical activity, and bladder cancer in a large prospective study. Cancer Epidemiol Biomarkers Prev, 17, 1214-21.   DOI   ScienceOn
14 Lee MY, Lin KD, Hsiao PJ, Shin SJ (2012). The association of diabetes mellitus with liver, colon, lung, and prostate cancer is independent of hypertension, hyperlipidemia, and gout in Taiwanese patients. Metabolism, 61, 242-9.   DOI
15 Li N, Yang L, Zhang Y, et al (2011). Human papillomavirus infection and bladder cancer risk: a meta-analysis. J Infect Dis, 204, 217-23.   DOI   ScienceOn
16 Funfstuck R, Nicolle LE, Hanefeld M, Naber KG (2012). Urinary tract infection in patients with diabetes mellitus. Clin Nephrol, 77, 40-8.   DOI
17 Liu X, Ji J, Sundquist K, Sundquist J, Hemminki K (2012). The impact of type 2 diabetes mellitus on cancer-specific survival: a follow-up study in Sweden. Cancer, 118, 1353-61.   DOI
18 Murta-Nascimento C, Schmitz-Drager BJ, Zeegers MP, et al (2007). Epidemiology of urinary bladder cancer: from tumor development to patient's death. World J Urol, 25, 285-95.   DOI   ScienceOn
19 Qin Q, Xu X, Wang X, et al (2013). Obesity and risk of bladder cancer: a meta-analysis of cohort studies. Asian Pac J Cancer Prev, 14, 3117-21.   과학기술학회마을   DOI   ScienceOn
20 Haggstrom C, Stocks T, Rapp K, et al (2011). Metabolic syndrome and risk of bladder cancer: prospective cohort study in the metabolic syndrome and cancer project (Me-Can). International journal of cancer. Journal international du cancer, 128, 1890-8.   DOI   ScienceOn
21 Freedman ND, Silverman DT, Hollenbeck AR, Schatzkin A, Abnet CC (2011). Association between smoking and risk of bladder cancer among men and women. JAMA, 306, 737-45.   DOI   ScienceOn
22 Gorbachinsky I, Akpinar H, Assimos DG (2010). Metabolic syndrome and urologic diseases. Rev Urol, 12, 157-80.
23 Hiatt RA, Fireman BH (1986). Serum cholesterol and the incidence of cancer in a large cohort. J Chronic Dis, 39, 861-70.   DOI
24 Hole DJ, Hawthorne VM, Isles CG, et al (1993). Incidence of and mortality from cancer in hypertensive patients. BMJ, 306, 609-11   DOI
25 Batty GD, Shipley MJ, Jarrett RJ, et al (2005). Obesity and overweight in relation to organ-specific cancer mortality in London (UK): findings from the original Whitehall study. Int J Obes, 29, 1267-74.   DOI
26 Holick CN, Giovannucci EL, Stampfer MJ, Michaud DS (2007). Prospective study of body mass index, height, physical activity and incidence of bladder cancer in US men and women. Int J Cancer, 120, 140-6.   DOI
27 Hu J, La Vecchia C, de Groh M, et al (2012). Dietary cholesterol intake and cancer. Ann Oncol, 23, 491-500.   DOI   ScienceOn
28 Jankovic S, Radosavljevic V (2007). Risk factors for bladder cancer. Tumori, 93, 4-12.
29 Borena W, Strohmaier S, Lukanova A, et al (2011). Metabolic risk factors and primary liver cancer in a prospective study of 578,700 adults. Int J Cancer, 43, 1-25.
30 Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ (2003). Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med, 348, 1625-38.   DOI   ScienceOn
31 Chen HS, Su LT, Lin SZ, et al (2012). Increased risk of urinary tract calculi among patients with diabetes mellitus - a population-based cohort study. Urology, 79, 86-92.   DOI   ScienceOn
32 Chow WH, Lindblad P, Gridley G, et al (1997). Risk of urinary tract cancers following kidney or ureter stones. J Natl Cancer Inst, 89, 1453-7.   DOI   ScienceOn
33 Cowey S, Hardy RW (2006). The metabolic syndrome: A highrisk state for cancer? Am J Pathol, 169, 1505-22.   DOI   ScienceOn
34 Currie CJ, Poole CD, Jenkins-Jones S, et al (2012). Mortality After Incident Cancer in People With and Without Type 2 Diabetes: Impact of metformin on survival. Diabetes Care, 35, 299-304.   DOI
35 Grove JS, Nomura A, Severson RK, Stemmermann GN (1991). The association of blood Pressure with cancer incidence in a prospective Study. Am J Epidemiol, 134, 942-7.
36 Dunn SE1, Kari FW, French J, et al (1997). Dietary restriction reduces insulin-like growth factor I levels, which modulates apoptosis, cell proliferation, and tumor progression in p53-deficient mice. Cancer Res, 57, 4667-72.
37 Eckel RH (2007). Treating dyslipidemia of the metabolic syndrome: where's the evidence? Nat Clin Pract Endocrinol Metab, 3, 437.   DOI   ScienceOn